Why Is There Such Reluctance to Discuss Natural Immunity?
Opinion | If you’re among those of us who aren’t tribally invested in COVID politics but would like good information about when life will resume as normal, chances are you’re interested in herd immunity. You’re likely not interested in having to rely on the Internet Archive for good information on herd immunity. Alas, it’s become a go-to place […]
Fertility Rates are Dropping Around the World
Story Highlights Despite ongoing concerns about overpopulation, birth rates are falling worldwide, and in many countries populations are projected to drop by half by the end of this century. Decreasing birth rates have been attributed to such social changes as increasing access to higher education for women, modern methods of contraception and economic considerations leading […]
Award Winning Investigative Journalist Provides Evidence of Origins of SARS-CoV-2
Although it has been suggested since the start of the pandemic in early 2020 that SARS-CoV-2, the new mutated coronavirus virus that causes COVID-19 disease, may have originated…
Former CDC Director Believes Coronavirus Was Made in a Lab
If you ask the average person about how they think the SARS-CoV-2 virus came about, chances are they will say something like: “It started with an infected bat in a wet market in Wuhan, China and somehow managed to get into humans.” That is the theory that consistently has been promoted by many scientists and public health officials since the World Health Organization (WHO) declared a COVID-19 pandemic.
After Blood Clot Reports, Some Countries Stop Using the Oxford/AstraZeneca COVID-19 Vaccine
The European Medicines Agency (EMA) held an emergency meeting on Mar. 18, 2021 after many European countries suspended use of the Oxford/AstraZeneca experimental COVID-19 vaccine due to reports of severe side effects including blood clots, low platelet counts and death.1 The EMA conducted a preliminary investigation into potential serious side effects and pronounced the vaccine […]
Moderna Expects $18.4 Billion in Sales from Its COVID-19 Vaccine This Year
Moderna, Inc. expects to generate $18.4 billion from sales of its experimental mRNA-1273 COVID-19 vaccine being distributed in the U.S. under an Emergency Use Authorization (EUA) granted by the Food and Drug Administration (FDA). This will be the first time that the U.S. based pharmaceutical company will make a profit since it was established in […]